Resumen
Administration of high dose cyclophosphamide (CY, 200 mg/kg body weight) to adult mice induces transient, nonspecific suppressor activity in the spleen of treated animals. Characterization of the CY-induced natural suppressor (NS) cells which inhibit mixed lymphocyte reactions revealed a heterogenous population of lymphocytes expressing the CD8 T cell marker and the B220 B cell marker, as well as cells bearing the granulocyte-monocyte marker CD11b. On a cell per cell basis the most potent of these suppressors were found to be positive for CD11b. Inhibitory activity was also detected in the CD8-, CD11b-, B220- compartment of CY-spleen, suggesting the presence of null NS cells. The fact that several phenotypically distinct cell populations contribute to the overall inhibitory effect of CY-spleen cells indicates that natural suppression defines an activity rather than a specific cell type. Interestingly, NS activity was observed to reside solely within the fraction of CY-spleen that is agglutinable with soybean agglutinin or wheat germ agglutinin, suggesting that expression of receptors for these plant lectins is a universal characteristic of CY-induced NS cells, regardless of their lineage. CY-spleen cell-mediated suppression of lymphoproliferative responses was found to be partially dependent on DNA synthesis and totally dependent on protein synthesis, but did not require cell-cell contact, indicating the production of soluble suppressor factor(s).
Idioma original | English |
---|---|
Páginas (desde-hasta) | 117-129 |
Número de páginas | 13 |
Publicación | Immunopharmacology |
Volumen | 25 |
N.º | 2 |
DOI | |
Estado | Published - 1993 |
Nota bibliográfica
Funding Information:This work was supported by grants from the Dalhousie Medical Research Foundation and the Natural Sciences and Engineering Research Council of Canada. The authors wish to thank Linda Best for flow cytofluorometric analysis and Angelique Sherwood for secretarial assistance in preparing this manuscript. Jane Brooks-Kaiser is the recipient of a Medical Research Council of Canada studentship.
ASJC Scopus Subject Areas
- Pharmacology